Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 98 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
971 11.8 months Newly diagnosed metastatic colorectal cancer 3 Chemotherapy
National Cancer Center Hospital Japan 6/2004
Treatment Details: Patients: This Phase II study involved 38 patients with previously untreated metastatic colorectal carcinoma. Treatment: The treatment consisted of oral fluoropyrimidine S-1 (a combinat
 
972 11.8 months metastatic colorectal cancer 4 Biologic therapy
Albert-Ludwigs-University Germany 6/2005
Treatment Details: Patients: This Phase I/II study involved 27 patients with metastatic colorectal cancer (23) or breast cancer (3). All patients but one had confirmed liver metastasis. Fifteen patients were
 
973 11.8 months metastatic colorectal cancer 4 Biologic therapy
Albert-Ludwigs-University Germany 6/2005
Treatment Details: Patients: This Phase I/II study involved 27 patients with metastatic colorectal cancer (23) or breast cancer (3). All patients but one had confirmed liver metastasis. Fifteen patients were
 
974 11.8 months GBM Radiation
University Hospital Lausanne Switzerland 3/2005
Treatment Details: Patients: This trial involved 206 patients with glioblastoma. Demographic information on the patients was not reported. The patients were randomly divided into two groups. In addition, al
 
975 11.8 months Advanced hepatocellular carcinoma 3 Chemotherapy
Immunotherapy
Hannover Medical School Germany 5/2010
Treatment Details: Patients: This study involved 40 patients with advanced hepatocellular carcinoma, 35 of these were male. The average age was 66.5 years. Treatment: Patients were given GV1001, which is
 
976 11.8 months Metastatic, castration-resistant prostate cancer 5 Hormone
Massachusetts General Hospital Cancer Center United States 1/2014
Treatment Details: Patients: This phase 3 study involved previously treated, metastatic castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A consisted of
 
977 11.8 months Metastatic breast cancer 4 Biologic therapy
The University of Texas MD Anderson Cancer Center United States 1/2012
Treatment Details: Patients: This phase II study involved 45 women with metastatic breast cancer who had received prior chemotherapy. The median age was 50 years. Treatment: Patients were treated with th
 
978 11.7 months Unresectable GBM 5 Biologic therapy
Chemotherapy
Duke University Medical Center United States 4/2013
Treatment Details: Patients: This phase 2 study involved 41 unresectable glioblastoma patients who had not been previously treated. The median patient age was 59.1 years and 26 were male. Treatment: Pati
 
979 11.7 months Advanced hepatocellular carcinoma 5 Biologic therapy
Massachusetts General Hospital United States 3/2013
Treatment Details: Patients: This phase 2 study involved 17 advanced hepatocellular carcinoma patients. The median patient age was 66 years and 88% were male. Treatment: Patients were treated with the bi
 
980 11.7 months Metastatic Colorectal Cancer 5 Chemotherapy
Universitat Auṭnoma de Barcelona Spain 4/2015
Treatment Details: Patients: This phase 3 study involved previously treated metastatic colorectal carcinoma patients who were divided into two separate treatment groups. Group A had 536 patients with an avera
 
Page 98 of 187  | Previous Page  | Next Page